Release Date: 28/02/13 14:31 Summary: Appendix 4D & Accounts Price Sensitive: Yes Download Document 1002.59KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%